Chemoinformaics analysis of 2-NAPHTHALEN-1-YLACETAMIDE
| Molecular Weight | 185.226 | nRot | 2 |
| Heavy Atom Molecular Weight | 174.138 | nRig | 11 |
| Exact Molecular Weight | 185.084 | nRing | 2 |
| Solubility: LogS | -6.926 | nHRing | 0 |
| Solubility: LogP | 9.347 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 2 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 11 |
| nHA | 1 | APOL | 29.2767 |
| nHD | 1 | BPOL | 11.3333 |
| QED | 0.37 |
| Synth | 3.786 |
| Natural Product Likeliness | 1.571 |
| NR-PPAR-gamma | 0.019 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.05 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.855 |
| MDCK | 0.00000758 |
| BBB | 0.838 |
| PPB | 1.00603 |
| VDSS | 5.329 |
| FU | 0.0184624 |
| CYP1A2-inh | 0.1 |
| CYP1A2-sub | 0.208 |
| CYP2c19-inh | 0.316 |
| CYP2c19-sub | 0.89 |
| CYP2c9-inh | 0.16 |
| CYP2c9-sub | 0.948 |
| CYP2d6-inh | 0.219 |
| CYP2d6-sub | 0.277 |
| CYP3a4-inh | 0.331 |
| CYP3a4-sub | 0.138 |
| CL | 8.243 |
| T12 | 0.029 |
| hERG | 0.021 |
| Ames | 0.04 |
| ROA | 0.036 |
| SkinSen | 0.954 |
| Carcinogencity | 0.029 |
| EI | 0.45 |
| Respiratory | 0.34 |
| NR-Aromatase | 0.621 |
| Antiviral | No |
| Prediction | 0.638211 |